Partnerships As a GI focused US healthcare company, collaboration is a core value and a key to our success US LINZESS®* available in U.S. through 50/50 collaboration with AbbVie Europe, Canada, Mexico CONSTELLA® available in certain European countries through partnership with AbbVie China, Hong Kong & Macau LINZESS® approved in Hong Kong, and in China through a collaboration with AstraZeneca Japan LINZESS® available in Japan through partnership with Astellas Rest of World License to develop and market linaclotide in remaining countries with AbbVie At Ironwood, we’re focused on three goals: transforming knowledge into medicines that make a difference for people living with gastrointestinal (GI) diseases, building a team that relentlessly pursues excellence and creating value that will inspire the continued support of our fellow shareholders. These are not easy tasks, and we recognize the value of collaboration in achieving them. Only by working together can we make medicines that make a difference in people’s lives. Corporate Partners Ironwood’s goal is to get our medicines to appropriate patients around the world in the most efficient way possible. We have a track record of establishing, operating and evolving high-performance partnerships globally. With our first internally-developed medicine, linaclotide, we’ve established a network of partners that can help us reach patients. Collaboration with Physician Professional Organizations and Patient Advocacy Groups We collaborate with the major GI physician and patient advocacy groups to support research and understanding with the aim to advance medicines and improve patient care. Partnering Opportunities As a GI focused, US healthcare company, we are interested in discussing opportunities to collaborate on GI products. We are also seeking partners in territories outside of the US for select current development programs. Please contact us with more details on your area of interest. Partner with Us Our Company Our Values Our Executive Team Our Board of Directors Open Payments and Transparency Our Product Discovery of Linaclotide Report a possible side effect Our Pipeline Partnerships Patients Join Us Open Positions Internships, Co-ops and Fellowships Things You Should Know Investors Events & Presentations Corporate Governance Financial Information Stock Information Investor FAQ Press Releases Investor Contacts Media Contact Us Follow Us Privacy Policy Terms of Use California Privacy Policy Site Map Contact Us Copyright © 2021, Ironwood Pharmaceuticals, Inc. All Rights Reserved LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved.